August 14, 2025

Effects of cerebellar intermittent theta-burst stimulation on patients with Alzheimer's disease: A randomized controlled trial.

View Full Paper

Ask AI

Bookmark

Active-iTBS significantly improved cognition in Alzheimer's patients, reducing CDR-SB scores by a mean change of -0.60.
Compared to sham-iTBS, the active-iTBS group showed greater increases in beta power and improvements in brain network functionality.
Randomized, double-blind clinical trial conducted over four weeks with 20 participants revealed promising results for iTBS therapy.
This finding highlights the potential of iTBS to enhance cognitive function and support brain health in Alzheimer's patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Randomized controlled trial improved cognition in Alzheimer's disease, suggesting iTBS may enhance brain function and glymphatic clearance.

Zhang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized controlled trial improved cognition in Alzheimer's disease, suggesting iTBS may enhance brain function and glymphatic clearance.